Henny Braund became Chief Executive of Anthony Nolan in January 2009. Henny works with staff at all levels: trustees and supporters, as well as external stakeholders such as government departments. She sees it as her role to deliver our vision, champion our cause, and inspire people to help our lifesaving work.
Previously Resources Director at Shelter, the housing charity, Henny draws on 20 years' experience in the voluntary sector. She is a Trustee for the Small Charities Coalition, and has been Chair for Aids and Housing (Health and Housing). She has also been a Trustee for Thamesreach and Shelter Trading.
Professor Madrigal joined Anthony Nolan in 1993. He created the Anthony Nolan Research Institute, recognised as one of the leading stem cell research institutes worldwide.
A key figure in haematology, Alejandro holds the Chair of Haematology at The Royal Free Hospital and is President of the European Group for Blood and Marrow Transplantation (EBMT). He has received many prestigious awards for his work and published over 200 papers in peer-reviewed journals (with more than 3,000 citations).
Alejandro has been Chair of AlloStem, the largest EU-funded project for immunotherapy, for four years. His main objectives are to improve the outcomes of stem cell transplants and to find new tools for cell therapy.
Ann O’Leary is Assistant Director of Donor and Transplantation Services at Anthony Nolan, and is responsible for overseeing the finding and facilitating of matches, as well as the donation process and support for those donating. Ann has been working in the area of altruistic donation for 11 years, having spent 4 years as Specialist Donor Recruiter with the Irish Blood Transfusion Service before moving to Anthony Nolan in 2010.
Ann is available to discuss issues around the need for donors, the finding and facilitating of donor matches and the donation process.
Richard Davidson joined Anthony Nolan as Director of Communications and Marketing in July 2010, overseeing significant rebranding and policy campaigns that helped refocus Anthony Nolan’s image and objectives for the 21st century. In 2016, he was given responsibility for the new Engagement Division, incorporating Fundraising as well as Marketing and Communications.
Previously a Director of MHP Health Mandate, Richard is perhaps best known for his role as Cancer Research UK's Director of Policy and Public Affairs where he oversaw the organisation's policy formulation, external affairs, public campaigning and the tobacco control work that eventually led to the UK smoking ban.
As Engagement chief, Richard can speak about focused issues such as brand campaigns, register development and fundraising, as well as give background detail around the organisation’s broader and longer-term goals.
Katie Begg joined Anthony Nolan in November 2012 as Head of Policy and Public Affairs. She leads our government and parliamentary relations activities, as well as stakeholder engagement within our sector. Katie takes responsibility for developing a clear public policy agenda for Anthony Nolan, driven by our core ambitions of securing a donor for every person who needs one, and improving the lives of blood cancer patients.
Before joining us, Katie held a number of positions within the public affairs and communications arena, including as Associate Director of a boutique political communications agency, and as European Public Affairs Manager at a FTSE 250 corporation. During this time she managed lobbying and policy campaigns for a range of organisations in the UK and Europe.
Dr Katy Latham is our Laboratory Director and Senior Research Scientist. She is responsible for the charity’s histocompatibility and immunogenetics services.
Katy started her career as a research and development scientist in the biotech industry, later gaining her PhD in Transplantation Genetics at the University of Manchester. For her thesis, Katy investigated the role of genotyping in predicting renal graft survival, working in collaboration with the NHS and industry. Katy has many years’ experience in her field, largely earned as a Clinical Scientist with the Central Manchester NHS Foundation Trust and by gaining the FRCPath.
At Anthony Nolan, Katy is working to push the boundaries of HLA testing for the charity’s register, by implementing new technologies and achieving high throughput of new donors added to the register. Katy also leads on a collaboration project with NHS Blood & Transplant, making her role key to improving the provision of UK bone marrow donors for blood cancer patients both in the UK and worldwide.
Director of Bioinformatics, Deputy Director of Research & Co-Director of Histocompatibility Laboratories, Anthony Nolan and Professor of Immunogenetics, UCL Cancer Institute, Professor Steven GE Marsh BSc, PhD, ARCS
Prof Marsh is Deputy Director of Research and Head of Immunogenetics at the Anthony Nolan Research Institute and Co-Director of our Histocompatibility Laboratory. He is also Professor of Immunogenetics at University College London and Chairman of the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System, and the WHO/IUIS Nomenclature Committee for Killer-cell Immunoglobulin-like Receptors (KIR). He is currently a President of the International HLA and Immunogenetics Workshop, President of the British Society for Histocompatibility and Immunogenetics (BSHI) and formerly President of the European Federation for Immunogenetics (EFI). In 2016 he became Editor-in-Chief of the journal HLA (formerly Tissue Antigens).
The aim of his research group is to improve the outcome of haematopoietic stem cell transplantation by understanding genetic differences, particularly the matching of HLA and KIR genes, between patients and donors. This work is undertaken by both bioinformatics and laboratory-based projects. He initiated the IPD-IMGT/HLA and IPD-KIR Databases, which are the worldwide resource for HLA and KIR sequences.